Matthé P. M. Burger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Matthé P. M. Burger has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
B. Hoschke
1 shared publicationErnst Stolz
Department of Dermatovenereology, Erasmus University, Rotterdam
1 shared publicationHenk W. A. De Bruijn
Department of Obstetrics and Gynecology, University Hospital, Groningen
1 shared publicationJitze M. Duk
Department of Obstetrics and Gynecology, University Hospital, Groningen
1 shared publicationM. Hohenfellner
1 shared publication- Marc Baay
P95 Clinical & Epidemiology Services, Leuven, Belgium
1 shared publication
Latest Publications
- 18 February 2016
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 95 (4) , 467-472
Complications after surgery for the relief of dyspareunia in women with lichen sclerosus: a case series
Introduction: The objective of this study was to analyse complications after surgical intervention on the vulva, especially with grafting of the vaginal epithelium, for the relief of dyspareunia in women with lichen sclerosus.Material and methods: A case series of 23 women with histologically confirmed lichen sclerosus who underwent vulvar surgery because of disabling sexual dysfunction. Surgical care was provided in a university hospital (tertiary referral center) between 2008 and 2012. The interventions were posterior vestibuloplasty (perineoplasty), dehooding of the glans clitoridis and anterior vestibuloplasty with grafts of vaginal epithelium.Results: A posterior vestibuloplasty was performed in all 23 women. Short‐term complications included postoperative infection with subtotal dehiscence of the advanced vaginal epithelium (n = 1), and reactivation of lichen sclerosus with the formation of bullae due to the postoperative discontinuation of dermatosteroid use (n = 1). The long‐term complications included localized pain (n = 3); although the relation with the surgical intervention was unclear. Four women underwent dehooding of the glans clitoridis, all without complications. Anterior vestibuloplasty with a free full‐thickness graft of vaginal mucosa was performed in five women. One woman underwent a second operation because of contraction and keratinization of the graft. The importance of estrogens for the condition of the graft was unclear.Conclusions: After reconstructive vulvar surgery in women with lichen sclerosus, issues such as infection, reactivation of the disease and pain require attention. The use of vaginal grafts in the repair of the anterior vestibule is a novel approach and deserves further exploration.
- 18 February 2016
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 95 (4) , 467-472
Complications after surgery for the relief of dyspareunia in women with lichen sclerosus: a case series
Introduction: The objective of this study was to analyse complications after surgical intervention on the vulva, especially with grafting of the vaginal epithelium, for the relief of dyspareunia in women with lichen sclerosus.Material and methods: A case series of 23 women with histologically confirmed lichen sclerosus who underwent vulvar surgery because of disabling sexual dysfunction. Surgical care was provided in a university hospital (tertiary referral center) between 2008 and 2012. The interventions were posterior vestibuloplasty (perineoplasty), dehooding of the glans clitoridis and anterior vestibuloplasty with grafts of vaginal epithelium.Results: A posterior vestibuloplasty was performed in all 23 women. Short‐term complications included postoperative infection with subtotal dehiscence of the advanced vaginal epithelium (n = 1), and reactivation of lichen sclerosus with the formation of bullae due to the postoperative discontinuation of dermatosteroid use (n = 1). The long‐term complications included localized pain (n = 3); although the relation with the surgical intervention was unclear. Four women underwent dehooding of the glans clitoridis, all without complications. Anterior vestibuloplasty with a free full‐thickness graft of vaginal mucosa was performed in five women. One woman underwent a second operation because of contraction and keratinization of the graft. The importance of estrogens for the condition of the graft was unclear.Conclusions: After reconstructive vulvar surgery in women with lichen sclerosus, issues such as infection, reactivation of the disease and pain require attention. The use of vaginal grafts in the repair of the anterior vestibule is a novel approach and deserves further exploration.
- 1 February 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (1) , e1019-e1019a
1019 Thrombocytosis is associated with a significant increase in cancer specific death rate after nephrectomy for patients with renal cell carcinoma
- 1 February 2012
- Published by Elsevier in European Urology Supplements
- Vol. 11 (1) , e1019-e1019a
1019 Thrombocytosis is associated with a significant increase in cancer specific death rate after nephrectomy for patients with renal cell carcinoma
- 1 March 1995
- Published by Wiley in Journal of Medical Virology
- Vol. 45 (3) , 342-347
Follow‐up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma
A synthetic peptide comprising amino acids 6-35 of HPV-16 E7 was used in an ELISA to screen sera taken from 31 cervical carcinoma patients. Sera obtained before and during treatment, and in follow-up, were tested for the presence of antibodies to this peptide. Sixteen patients with negative pretreatment serum determination remained negative during treatment and follow-up. Of the 15 patients with positive pretreatment sera, 12 showed a decrease in anti-E7 6–35 antibody level during treatment. During follow-up an increase in anti-E76–35 antibody level was observed in 6 out of 7 patients with progressive or recurrent disease, whereas all patients who remained in complete remission showed stable or further decreasing antibody levels. During the course of disease of the 15 seropositive patients, serum anti-E76–35 antibody levels were compared with serum squamous cell carcinoma antigen (SCC-Ag) profiles, a clinically useful tumor marker in the management of cervical cancer patients. Similar patterns were observed in 10 out of 15 patients. The results of this study suggest that in a subset of cervical cancer patients, anti-E76–35 antibody response against HPV-16 E7 at least partially depends on the presence of viable tumor lesions, and that to some extent the anti-E7 profile reflects the course of disease.
- 1 March 1995
- Published by Wiley in Journal of Medical Virology
- Vol. 45 (3) , 342-347
Follow‐up of antibody responses to human papillomavirus type 16 E7 in patients treated for cervical carcinoma
A synthetic peptide comprising amino acids 6-35 of HPV-16 E7 was used in an ELISA to screen sera taken from 31 cervical carcinoma patients. Sera obtained before and during treatment, and in follow-up, were tested for the presence of antibodies to this peptide. Sixteen patients with negative pretreatment serum determination remained negative during treatment and follow-up. Of the 15 patients with positive pretreatment sera, 12 showed a decrease in anti-E7 6–35 antibody level during treatment. During follow-up an increase in anti-E76–35 antibody level was observed in 6 out of 7 patients with progressive or recurrent disease, whereas all patients who remained in complete remission showed stable or further decreasing antibody levels. During the course of disease of the 15 seropositive patients, serum anti-E76–35 antibody levels were compared with serum squamous cell carcinoma antigen (SCC-Ag) profiles, a clinically useful tumor marker in the management of cervical cancer patients. Similar patterns were observed in 10 out of 15 patients. The results of this study suggest that in a subset of cervical cancer patients, anti-E76–35 antibody response against HPV-16 E7 at least partially depends on the presence of viable tumor lesions, and that to some extent the anti-E7 profile reflects the course of disease.